about
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases.The microtubule-associated protein EB1 maintains cell polarity through activation of protein kinase C.Directed migration of mouse macrophages in vitro involves myristoylated alanine-rich C-kinase substrate (MARCKS) protein.A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.In Vitro Neutrophil Migration Requires Protein Kinase C-Delta (δ-PKC)-Mediated Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Phosphorylation.MARCKS protein overexpression in inflammatory breast cancer.Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.Specifying protein kinase C functions in melanoma.Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.Role of WNT7B-induced noncanonical pathway in advanced prostate cancer.Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics.MARCKS promotes invasion and is associated with biochemical recurrence in prostate cancer.A novel predictor of cancer malignancy: up-regulation of myristoylated alanine-rich C kinase substrate phosphorylation in lung cancer.Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers.MARCKS and MARCKS-like proteins in development and regeneration.The Rules and Functions of Nucleocytoplasmic Shuttling Proteins.Overexpression of MARCKS indicates a poor prognosis of oral squamous cell carcinoma
P2860
Q34857146-D5F357F8-8515-4DA2-AC59-20ED1E0A7DCAQ34987170-91EEA6B0-7D40-4865-9A2E-4CCE34634EFAQ35048920-2FF50557-4FAD-451B-88B9-7C31C1228D7FQ35675200-3170877E-71FB-4F26-AD6C-F645405BCF8BQ36188854-D1B00E1B-8A1B-4382-8C8D-BF8D19A2EAD4Q36244135-2C419B94-7D2E-4557-B57B-6233909F8526Q36954876-7E6A488C-D9B0-4D5B-B43F-C186E409D960Q37701585-AFAA8A95-331E-4140-BE2F-C90ED20ED044Q37746021-217EF7E9-75AC-49D1-BD04-17204C9B2C53Q38009398-E5AD987B-2AB6-445D-9D3B-87B0008F73EAQ38976447-C21D13B3-FDBF-4DBE-B15B-DB9D0CF1CAF6Q39012262-2E0EF845-6AD4-4864-BBA2-83B113F86840Q39198747-639653FE-8089-477E-806E-5853EA563E51Q39602023-9808BEEE-D0DB-41AC-B653-FE9F78B9F183Q42700841-755CFF1B-030D-4187-A862-5879ECABA27AQ42735841-5E3F4B56-F67D-4EE1-BB0F-FBF3CF3321B1Q43407097-B134D5E0-D4F4-4B5B-B60D-57D98D39604AQ47181311-764FFC0E-DC7A-4435-A007-C98E924FD5E0Q47642445-A1E571F6-9A68-40B6-855E-4A6BBB685F19Q54978517-5A33927E-445A-408A-B165-E2BBE202340EQ54987435-1EA4A8B4-FB3E-4C4D-8589-E2FD33CA6139Q58772590-3CC0418B-BBBA-465A-9DBD-6274E474B4CD
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
PhosphoMARCKS drives motility of mouse melanoma cells.
@ast
PhosphoMARCKS drives motility of mouse melanoma cells.
@en
type
label
PhosphoMARCKS drives motility of mouse melanoma cells.
@ast
PhosphoMARCKS drives motility of mouse melanoma cells.
@en
prefLabel
PhosphoMARCKS drives motility of mouse melanoma cells.
@ast
PhosphoMARCKS drives motility of mouse melanoma cells.
@en
P2860
P1433
P1476
PhosphoMARCKS drives motility of mouse melanoma cells.
@en
P2093
Susan A Rotenberg
Xiangyu Chen
P2860
P304
P356
10.1016/J.CELLSIG.2010.03.003
P577
2010-03-06T00:00:00Z